Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?

NCT02903082 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.

NCT NCT02903082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02903082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?
Lead sponsor
University Hospital, Limoges
Phase
Observational
Overall status
Terminated
Start date
April 30, 2015
Completion date
January 31, 2018
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory response syndrome, systemic, severe sepsis